Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
![]()
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
New schools, restructuring part of streamlined Faculty of Health Sciences
2017-10-12
From the left, front are: Dr Jocelyn Naicker,
Prof Gert van Zyl, Prof Magda Mulder;
back from left: Prof Chris Viljoen,
Marlene Viljoen, Deputy Director: Faculty of Health Sciences;
Prof Nathaniel Mofolo; and Prof Santie van Vuuren.
Photo: Rulanzen Martin
Numerous developments, such as the creation of two new schools and one newly restructured School of Medicine in the Faculty of Health Sciences at the University of the Free State (UFS), will catapult this renowned faculty to even greater heights.
Five-school structure to increase access
A five-school structure was proposed at the annual Faculty Management retreat in July 2016. The previous three-school model included the Schools of Medicine, Nursing, and Allied Health Professions.
The current School of Medicine has been restructured and will henceforth be known as the School of Clinical Medicine. The Schools of Pathology and Biomedical Sciences have been added to the faculty. “So, three new schools were in fact created within the faculty,” said Prof Gert van Zyl, Dean of the faculty.
“There was also a request from the National Health Laboratory Services to group academics that is rendering services in pathology into a new School of Pathology.” This is what motivated the faculty management to create two new schools.
Esteemed academics appointed
With the creation of the new schools, there were also new appointments within the Faculty of Health Sciences. Dr Jocelyn Naicker has been appointed as the new part-time Head of the School of Pathology, Prof Chris Viljoen was appointed as the part-time Head of the School of Biomedical Sciences, and Prof Nathaniel Mofolo as the new Head of the School of Clinical Medicine. Prof Santie van Vuuren remains Head of the School of Allied Health Professions, and Prof Magda Mulder as the head of the School of Nursing.
Research outputs to remain as usual
The addition of the new schools will not impact research output. “In the past, research was done across departmental boundaries between all the departments in the faculty,” Prof Van Zyl said. The advantages of adding two additional schools are that the workload will be distributed among the five schools. The heads of schools will work within their respective disciplines and related areas, and will eliminate the duplication of administrative functions.